Nikon India forays into healthcare sector through System Product Microscopy business

The product is targeted at premier research institutes, research centers funded and established by the Govt of India, academic educational institutions, clinical centres i.e- Hospitals and Medical Research institutes, etc to boost research and development in medicine.

Published On 2022-11-16 05:45 GMT   |   Update On 2022-11-16 06:21 GMT

New Delhi: Imaging products company Nikon India Private Ltd. has announced its foray into India's healthcare sector through System Product Microscopy business. The company aims at facilitating direct sales, service, and distribution for its Microscopy Solutions.

Nikon's newly launched product AXR Point scanning confocal microscope has the capability to provide a Field of View of 25mm in one single shot which gives strength researchers to generate most accurate statistical data while imaging.

Advertisement
The product is targeted at premier research institutes, research centers funded and established by the Govt of India, academic educational institutions, clinical centres i.e- Hospitals and Medical Research institutes, etc to boost research and development in medicine.
Mr. Sajjan Kumar, Managing Director of Nikon India Pvt. Ltd. said, "Our legacy of manufacturing microscope dates back to 1917 and is more than 100 years old. Today, Nikon microscopy is known in the industry for its precision and the best quality of optics manufactured, right from lens manufacturing to the finished product. This segment offers huge potential, and we are extremely upbeat about its growth prospects. We plan to install AXR system in a few research institutes in India namely IIT Bhilai, IIT Mumbai, ACTREC Mumbai to name a few. Our expected annual turnover for FY 22-23 will be around 5% of Nikon's India operations and we anticipate it to grow 10% plus by end of next year". Nikon Healthcare business in India has exceeded our budget and we hope this growth trajectory continues in future.
Nikon's healthcare Product Range consists of General Microscope, IVF Station and System Microscope Solutions. In India, the microscopy market is expected to grow at a rate of 7-10% during the same period.

Read also: AstraZeneca Imfinzi plus chemotherapy recommended for marketing authorisation in EU for advanced biliary tract cancer

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News